Collaborations, Competitor News

Target RWE and the American Association for the Study of Liver Diseases Announce Research Agreement for Cirrhosis Quality Collaborative

DURHAM, N.C., Oct. 18, 2022 /PRNewswire/ — Today, real world evidence (RWE) leader Target RWE announced a partnership with the American Association for the Study of Liver Diseases (AASLD) to support its Cirrhosis Quality Collaborative (CQC), effective immediately. With this new strategic partnership, Target RWE will contribute its deep knowledge of long-term, observational studies, and industry-leading…

AI, Collaborations, Competitor News, Data Partnership, Oncology, Pharma

GSK announces expanded collaboration with Tempus in precision medicine to accelerate R&D

GSK plc (LSE/NYSE: GSK) and Tempus, a US-based precision medicine company, have entered into a three-year collaboration agreement that provides GSK with access to Tempus’ AI-enabled platform, including its library of de-identified patient data. Through its leading Artificial Intelligence and Machine Learning (AI/ML) capability, GSK will work together with Tempus…

Collaborations, Competitor News, Data Partnership, Synthetic Data

Syntegra and the Institute for Health Metrics Expand Strategic Partnership to Bring Privacy-Guaranteed Healthcare Data to Life Sciences

SAN FRANCISCO, Oct. 18, 2022 /PRNewswire/ — Syntegra, a leader in synthetic data generation, and the Institute for Health Metrics (IHM), the not-for-profit hospital data collaborative, today  announced an expanded partnership to enable easier and faster access to millions of privacy-guaranteed electronic health records for life sciences companies. This strategic partnership combines the privacy-preserving capabilities…

Competitor News, Europe, International, M&A, Oncology

TriNetX Acquires European Regulatory-Grade Real-World Evidence Leader OncologyInformationService and CancerDataNet

CAMBRIDGE, Mass., Oct. 18, 2022 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the acquisition of OncologyInformationService e.K. (OIS) and its subsidiary CancerDataNet GmbH (CDN), a German-based company and the subsidiary a Swiss-based company. Both companies provide real-world data…

Competitor News, HR

M2GEN Appoints Kyle Dunn as Chief Revenue Officer to Deliver Next Phase of Company’s Growth

Dunn brings expertise in developing data and analytical products for commercialization to leading biopharmaceutical, informatics, diagnostic and precision oncology companies. TAMPA, Fla., Oct. 17, 2022 /PRNewswire/ — M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, today announced the appointment of Kyle Dunn to its executive team as Chief Revenue…

Competitor News, HR

Datavant taps Douglas Fridsma for Chief Medical Informatics Officer

Douglas Fridsma, an internationally recognized leader in health informatics, standards, interoperability and health IT strategy who has worked in academics, government, non-profit, healthcare and innovation companies, has taken on a new challenge as Chief Medical Informatics Officer at Datavant. Prior roles include: Head of Government Partnerships – Datavant President and…

Competitor News, RWE Study

A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia

PURPOSE Primary prophylactic colony-stimulating factors (PP-CSFs) are prescribed to reduce febrile neutropenia (FN) but their benefit for intermediate FN risk regimens is uncertain. Within a pragmatic, randomized trial of a standing order entry (SOE) PP-CSF intervention, we conducted a substudy to evaluate the effectiveness of SOE for patients receiving intermediate-risk…

Collaborations, Competitor News

Dstillery Partners with PurpleLab to Leverage Real-World Data in its Custom Patient Targeting Solution

NEW YORK, Oct. 13, 2022 /PRNewswire/ — Dstillery, the custom audience solutions company, partnered with PurpleLab, Inc., a healthcare data and analytics platform provider, to power its Custom Patient Targeting solution with real-world data, including ICD-10 codes from claims data, making the solution even more custom and precise.  Powered by Dstillery’s patented ID-free™ technology, Custom Patient…

Competitor News, RWE Study

COVID-19 in Unvaccinated Patients Increases Long-Term Cardiovascular Disease Risk

Unvaccinated survivors of COVID-19 infection were found to be at increased risk for cardiovascular disease (CVD) compared with unvaccinated individuals with no history of infection. These study findings were published in eClinicalMedicine. Source: https://www.infectiousdiseaseadvisor.com/home/topics/covid19/long-term-cardiovascular-disease-risk-after-covid-19/